NRIX
Nurix Therapeutics, Inc.
+0.48 (+1.91%)25.63USD516K成交股數2.7B市值–本益比(近四季)72.3股價營收比-79.5%營收年增(近四季)2026-10-08下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 15 · 2.1M · 3 |
| 其中 10b5-1 計畫賣出 | 12 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 3.0M |
| 近 180 天 淨額 | −3.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 | 09-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 5.4K | 25.69 | 138K | 9.5K | SEC |
| 2026-09-02 | 09-02 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 5.8K | 8.72 | 50K | 14.9K | SEC |
| 2026-09-02 | 09-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 400 | 26.64 | 11K | 9.1K | SEC |
| 2026-09-01 | 09-01 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 1.5K | 1.86 | 3K | 119K | SEC |
| 2026-09-01 | 09-01 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.5K | 25.47 | 37K | 117K | SEC |
| 2026-08-05 | 08-05 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 4.4K | 1.86 | 8K | 122K | SEC |
| 2026-08-05 | 08-05 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.4K | 25.00 | 109K | 117K | SEC |
| 2026-08-04 | 08-05 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.6K | 24.64 | 64K | 117K | SEC |
| 2026-08-04 | 08-05 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.5K | 23.87 | 36K | 120K | SEC |
| 2026-08-04 | 08-04 | van Houte Hans | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.8K | 23.89 | 43K | 43.1K | SEC |
| 2026-08-04 | 08-04 | van Houte Hans | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.0K | 24.65 | 73K | 40.2K | SEC |
| 2026-08-03 | 08-03 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 16.6K | 23.05 | 382K | 9.1K | SEC |
| 2026-08-03 | 08-03 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 5.8K | 8.72 | 50K | 25.7K | SEC |
| 2026-07-30 | 07-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 3.6K | – | – | 47.8K | SEC |
| 2026-07-30 | 07-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 2.9K | – | – | 122K | SEC |
| 2026-07-30 | 07-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 3.8K | – | – | 119K | SEC |
| 2026-07-30 | 07-30 | van Houte Hans | Chief Financial Officer | S 公開市場賣出 | 2.8K | 23.38 | 67K | 44.9K | SEC |
| 2026-07-30 | 07-30 | Ring Christine | Chief Legal Officer | S 公開市場賣出 | 3.8K | 23.38 | 90K | 19.9K | SEC |
| 2026-07-30 | 07-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.6K | – | – | 23.8K | SEC |
| 2026-07-30 | 07-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.8K | – | – | 17.3K | SEC |
| 2026-07-30 | 07-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 3.8K | – | – | 41.3K | SEC |
| 2026-07-30 | 07-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.9K | – | – | 44.2K | SEC |
| 2026-07-30 | 07-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 3.6K | – | – | 125K | SEC |
| 2026-07-30 | 07-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 2.9K | – | – | 20.2K | SEC |
| 2026-07-30 | 07-30 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出 | 3.8K | 23.38 | 90K | 121K | SEC |
| 2026-07-02 | 07-02 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 5.8K | 8.72 | 50K | 24.6K | SEC |
| 2026-07-02 | 07-02 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 5.2K | 1.86 | 10K | 18.8K | SEC |
| 2026-07-02 | 07-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 11.0K | 23.56 | 259K | 13.6K | SEC |
| 2026-06-25 | 06-25 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 15.6K | 8.72 | 136K | 42.5K | SEC |
| 2026-06-25 | 06-25 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 13.3K | 7.26 | 97K | 26.9K | SEC |
| 2026-06-25 | 06-25 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 28.9K | 20.06 | 580K | 13.6K | SEC |
| 2026-06-25 | 06-25 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.4K | 20.00 | 108K | 115K | SEC |
| 2026-06-02 | 06-02 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.4K | 1.86 | 6K | 21.7K | SEC |
| 2026-06-02 | 06-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 8.1K | 16.60 | 135K | 13.6K | SEC |
| 2026-05-05 | 05-05 | van Houte Hans | Chief Financial Officer | S 公開市場賣出(10b5-1) | 582 | 17.18 | 10K | 37.6K | SEC |
| 2026-05-05 | 05-05 | van Houte Hans | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.5K | 16.58 | 223K | 38.2K | SEC |
| 2026-05-04 | 05-04 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 8.1K | 16.96 | 138K | 18.3K | SEC |
| 2026-05-01 | 05-01 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 5.4K | 16.76 | 90K | 26.5K | SEC |
| 2026-04-30 | 04-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 2.0K | – | – | 117K | SEC |
| 2026-04-30 | 04-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 3.8K | – | – | 51.2K | SEC |
| 2026-04-30 | 04-30 | van Houte Hans | Chief Financial Officer | S 公開市場賣出 | 2.4K | 16.65 | 40K | 51.6K | SEC |
| 2026-04-30 | 04-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.9K | – | – | 54.0K | SEC |
| 2026-04-30 | 04-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.0K | – | – | 47.4K | SEC |
| 2026-04-30 | 04-30 | Ring Christine | Chief Legal Officer | S 公開市場賣出 | 3.2K | 16.65 | 54K | 31.8K | SEC |
| 2026-04-30 | 04-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 2.9K | – | – | 35.1K | SEC |
| 2026-04-30 | 04-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.8K | – | – | 32.2K | SEC |
| 2026-04-30 | 04-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 2.0K | – | – | 28.5K | SEC |
| 2026-04-30 | 04-30 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出 | 3.2K | 16.65 | 54K | 120K | SEC |
| 2026-04-30 | 04-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 2.9K | – | – | 124K | SEC |
| 2026-04-30 | 04-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 3.8K | – | – | 121K | SEC |
| 2026-04-02 | 04-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 8.1K | 15.24 | 124K | 26.5K | SEC |
| 2026-03-02 | 03-02 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 8.1K | 15.44 | 126K | 34.6K | SEC |
| 2026-02-09 | 02-09 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 14.3K | 16.66 | 238K | 42.7K | SEC |
| 2026-02-03 | 02-03 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 31.3K | 0.84 | 26K | 115K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 2.0K | – | – | 54.8K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 1.9K | – | – | 52.8K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出 | 98 | 17.37 | 2K | 83.7K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | S 公開市場賣出 | 4.8K | 16.58 | 80K | 83.8K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 2.9K | – | – | 88.6K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 3.8K | – | – | 85.7K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 2.0K | – | – | 82.0K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.8K | – | – | 58.6K | SEC |
| 2026-01-30 | 01-30 | Hansen Gwenn | Chief Scientific Officer | M 選擇權執行 | 3.2K | – | – | 80.0K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | S 公開市場賣出 | 73 | 17.37 | 1K | 45.4K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | S 公開市場賣出 | 4.3K | 16.58 | 72K | 57.1K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 2.9K | – | – | 61.4K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | S 公開市場賣出 | 3.6K | 16.58 | 59K | 45.5K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.9K | – | – | 49.1K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 3.8K | – | – | 46.2K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.0K | – | – | 42.5K | SEC |
| 2026-01-30 | 01-30 | van Houte Hans | Chief Financial Officer | M 選擇權執行 | 2.9K | – | – | 40.5K | SEC |
| 2026-01-30 | 01-30 | Ring Christine | Chief Legal Officer | S 公開市場賣出 | 88 | 17.37 | 2K | 57.0K | SEC |
| 2026-01-20 | 01-20 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.8K | 1.86 | 7K | 54.7K | SEC |
| 2026-01-20 | 01-20 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 3.8K | 18.42 | 69K | 50.9K | SEC |
| 2025-12-18 | 12-18 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 200 | 18.56 | 4K | 50.9K | SEC |
| 2025-12-18 | 12-18 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 3.6K | 17.87 | 64K | 51.1K | SEC |
| 2025-12-18 | 12-18 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 3.8K | 1.86 | 7K | 54.7K | SEC |
| 2025-11-24 | 11-24 | Ring Christine | Chief Legal Officer | S 公開市場賣出(10b5-1) | 37.6K | 17.07 | 642K | 50.9K | SEC |
| 2025-11-24 | 11-24 | Ring Christine | Chief Legal Officer | M 選擇權執行 | 37.6K | 1.86 | 70K | 88.5K | SEC |
| 2025-11-03 | 11-03 | van Houte Hans | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.3K | 12.56 | 79K | 37.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 8.8M | 213M | 新進 | 新進 |
| Vestal Point Capital, LP | 8.1M | 195M | 新進 | 新進 |
| Deep Track Capital, LP | 7.7M | 188M | 新進 | 新進 |
| Rubric Capital Management LP | 7.2M | 175M | 新進 | 新進 |
| FMR LLC | 5.5M | 133M | 新進 | 新進 |
| MORGAN STANLEY | 4.8M | 116M | 新進 | 新進 |
| STATE STREET CORP | 4.7M | 113M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 4.7M | 113M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | 109M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 4.3M | 105M | 新進 | 新進 |
| Redmile Group, LLC | 4.1M | 98.8M | 新進 | 新進 |
| GENERAL ATLANTIC, L.P. | 3.0M | 73.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 61.6M | 新進 | 新進 |
| Pictet Asset Management Holding SA | 2.4M | 57.0M | 新進 | 新進 |
| 方舟(伍德) ARK Investment Management LLC | 1.8M | 43.5M | 新進 | 新進 |
| Capital World Investors | 1.8M | 43.4M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 1.6M | 38.2M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | 36.0M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 1.5M | 35.8M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 1.5M | 35.5M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.4M | 34.7M | 新進 | 新進 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.3M | 31.5M | 新進 | 新進 |
| BRAIDWELL LP | 1.3M | 31.2M | 新進 | 新進 |
| Kynam Capital Management, LP | 1.2M | 29.0M | 新進 | 新進 |
| Woodline Partners LP | 1.1M | 25.8M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 212 +15 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 212 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 117M · 100.0% |
| 合計季末市值 | 2.7B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 18.0M |
|---|---|
| 與上期比 | -0.2% |
| 佔流通股數 | 17.30% |
| 日均成交量 | 1.1M |
| 回補天數 | 15.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 18.0M | -0.2% | 17.30% | 1.1M | 15.9 |
| 2026-08-14 | 18.0M | -2.0% | 17.33% | 993K | 18.1 |
| 2026-07-31 | 18.4M | +2.1% | 17.68% | 1.0M | 18.0 |
| 2026-07-15 | 18.0M | +1.0% | 17.32% | 1.3M | 13.9 |
| 2026-06-30 | 17.8M | -11.1% | 17.15% | 3.3M | 5.4 |
| 2026-06-15 | 20.0M | +3.6% | 19.30% | 4.1M | 4.9 |
| 2026-05-29 | 19.3M | +3.7% | 18.62% | 1.3M | 14.9 |
| 2026-05-15 | 18.6M | -3.0% | 17.95% | 839K | 22.2 |
| 2026-04-30 | 19.2M | 0.0% | 18.50% | 789K | 24.3 |
| 2026-04-15 | 19.2M | +5.9% | 18.50% | 1.4M | 14.1 |
| 2026-03-31 | 18.1M | +12.1% | 17.47% | 1.6M | 11.6 |
| 2026-03-13 | 16.2M | +1.3% | 15.59% | 825K | 19.6 |
| 2026-02-27 | 16.0M | +4.7% | 15.39% | 787K | 20.3 |
| 2026-02-13 | 15.2M | +1.9% | 14.69% | 848K | 18.0 |
| 2026-01-30 | 15.0M | -1.6% | 14.42% | 1.3M | 11.7 |
| 2026-01-15 | 15.2M | +3.8% | 14.64% | 1.4M | 11.0 |
| 2025-12-31 | 14.6M | +7.3% | 14.11% | 1.6M | 9.4 |
| 2025-12-15 | 13.6M | -5.8% | 13.15% | 2.2M | 6.2 |
| 2025-11-28 | 14.5M | +2.9% | 13.96% | 1.6M | 9.1 |
| 2025-11-14 | 14.1M | +7.3% | 13.56% | 1.5M | 9.6 |
| 2025-10-31 | 13.1M | -5.4% | 12.64% | 2.2M | 6.0 |
| 2025-10-15 | 13.9M | +6.4% | 13.36% | 1.4M | 9.8 |
| 2025-09-30 | 13.0M | -0.1% | 12.56% | 1.2M | 11.1 |
| 2025-09-15 | 13.0M | +1.9% | 12.57% | 858K | 15.2 |
| 2025-08-29 | 12.8M | -0.5% | 12.34% | 789K | 16.2 |
| 2025-08-15 | 12.9M | -1.2% | 12.41% | 548K | 23.5 |